|
CA2151945A1
|
|
Assay and treatment for demyelinating diseases such as multiple sclerosis
|
|
EP0674661A1
|
|
Assay and treatment for demyelinating diseases such as multiple sclerosis
|
|
CA2133995A1
|
|
Method and composition for the treatment of disorders involving immunological dysfunction
|
|
AU4110493A
|
|
Method and composition for the treatment of disorders involving immunological dysfunction
|
|
WO9218158A1
|
|
Method and composition for the treatment of herpes related disorders
|
|
WO9116819A1
|
|
Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein
|
|
US4966753A
|
|
Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
|
